Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sinupret Extract in Chronic Rhinosinusitis
NCT02746042Phase 3Completed
- Sponsor
- Bionorica
- Start
- Apr 2016
- Primary completion
- Jul 2017
- Modality
- Botanical Extract
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in chronic rhinosinusitis (CRS) comparing Sinupret extract with Placebo (2 arms). Primary endpoint: Major Symptom Score assessed by Investigator at 16 weeks. Started Apr 2016; status: completed.
02
Drugs
Sambucus nigra flower
03
Conditions
chronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on NCT02746042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02746042.